Literature DB >> 9129068

Detection of serum antibodies to a Kaposi's sarcoma-associated herpesvirus-specific peptide.

D A Davis1, R W Humphrey, F M Newcomb, T R O'Brien, J J Goedert, S E Straus, R Yarchoan.   

Abstract

Kaposi's sarcoma (KS)-associated herpesvirus/human herpesvirus type 8 (KSHV/HHV-8) may play an etiologic role in the pathogenesis of KS. In an attempt to assess KSHV/HHV-8 infection, an ELISA was developed using an 18-amino acid peptide from a putative minor capsid protein of KSHV/HHV-8 conjugated to bovine serum albumin. Overall, sera from human immunodeficiency virus type 1 (HIV-1)-positive patients with KS had a higher reactivity in the assay than did sera from HIV-1-positive patients without KS (P = .018). Of 35 HIV-1-positive patients with KS, 60% were antibody positive, compared with 27% of 33 HIV-1-positive patients without KS. Of 30 healthy blood donors, 20% were antibody positive. The ELISA responses did not correlate with antibody titers to Epstein-Barr virus. Given the homology and antigenic relatedness between KSHV/HHV-8 and Epstein-Barr virus, serologic assays involving unique KSHV/HHV-8 peptides may prove to be valuable in defining the epidemiology and clinical expression of this virus.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9129068     DOI: 10.1086/516444

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  Comparison of serologic assays and PCR for diagnosis of human herpesvirus 8 infection.

Authors:  T J Spira; L Lam; S C Dollard; Y X Meng; C P Pau; J B Black; D Burns; B Cooper; M Hamid; J Huong; K Kite-Powell; P E Pellett
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Human Herpesvirus 8 Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-08       Impact factor: 3.725

3.  Use of epidemiologically well-defined subjects and existing immunofluorescence assays to calibrate a new enzyme immunoassay for human herpesvirus 8 antibodies.

Authors:  J N Martin; Z Amad; C Cossen; P K Lam; D H Kedes; K A Page-Shafer; D H Osmond; B Forghani
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

Review 4.  Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus.

Authors:  C Boshoff; R A Weiss
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

5.  Highly sensitive assay for human herpesvirus 8 antibodies that uses a multiple antigenic peptide derived from open reading frame K8.1.

Authors:  Lee L Lam; Chou-Pong Pau; Sheila C Dollard; Philip E Pellett; Thomas J Spira
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

6.  New immunofluorescence assays for detection of Human herpesvirus 8-specific antibodies.

Authors:  N Inoue; E C Mar; S C Dollard; C P Pau; Q Zheng; P E Pellett
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

7.  Identification of antigenic proteins encoded by human herpesvirus 8 and seroprevalence in the general population and among patients with and without Kaposi's sarcoma.

Authors:  H Katano; T Iwasaki; N Baba; M Terai; S Mori; A Iwamoto; T Kurata; T Sata
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

8.  High human herpesvirus 8 seroprevalence in the homosexual population in Switzerland.

Authors:  N Regamey; G Cathomas; M Schwager; M Wernli; T Harr; P Erb
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

9.  Mapping and serodiagnostic application of a dominant epitope within the human herpesvirus 8 ORF 65-encoded protein.

Authors:  C P Pau; L L Lam; T J Spira; J B Black; J A Stewart; P E Pellett; R A Respess
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

10.  Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression.

Authors:  R Sun; S F Lin; K Staskus; L Gradoville; E Grogan; A Haase; G Miller
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.